1
Robert E Newell, Robert A Fitzsimmons: Devices for administering medicaments to patients. Glaxo Group, McAulay Fields Fisher Goldstein & Nissen, December 9, 1986: US04627432 (285 worldwide citation)

A device for administering medicaments to patients comprises a housing containing a cylindrical chamber. A support is arranged inside the chamber to support a carrier, such as a blister pack. The blister pack has a plurality of containers or blisters arranged in a circle. When a blister pack is loca ...


2
Robert E Newell, Paul K Rand, Robert A Fitzsimmons: Devices for administering medicaments to patients. Glaxo Group, McAulay Fields Fisher Goldstein & Nissen, March 14, 1989: US04811731 (250 worldwide citation)

A device is provided for administering medicaments in solid finely divided form to patients. The device comprising a housing, a tray mounted in the housing and movable between first and second positions relative to the housing, a support disc provided on the tray and adapted to receive a carrier pro ...


3
Willem Peter Christiaan Stemmer, Robert J Lipshutz: End-complementary polymerase reaction. Glaxo Group, Townsend and Townsend & Crew, November 10, 1998: US05834252 (224 worldwide citation)

The present invention is directed to a process for amplifying and detecting any target nucleic acid sequence contained in a nucleic acid or mixture thereof and for assembling large polynucleotides from component polynucleotides, each involving generating concatemers formed by PCR amplification of ov ...


4
Paul K Rand, Philip M Regan: Triggered application device for medicament to be more descriptive of the invention. Glaxo Group, Darby & Darby, August 11, 1992: US05137516 (208 worldwide citation)

The application describes an administering device, in particular a self-injecting device, comprising a body for holding a container of a substance to be administered, a release mechanism, and means controlled by the release mechanism to discharge the said substance. The body is formed of two parts, ...


5
Willem P C Stemmer, Robert J Lipshutz: End-complementary polymerase reaction. Glaxo Group, Affymetrix, Townsend & Townsend & Crew, July 27, 1999: US05928905 (200 worldwide citation)

The present invention is directed to a process for amplifying and detecting any target nucleic acid sequence contained in a nucleic acid or mixture thereof and for assembling large polynucleotides from component polynucleotides, each involving generating concatemers formed by PCR amplification of ov ...


6
William J Dower, Gregory L Heinkel, Larry Mattheakis, Peter J Schatz: Use of modified tethers in screening compound libraries. Glaxo Group, Joe Liebeschuetz, Lauren L Stevens, September 28, 1999: US05958703 (161 worldwide citation)

The invention provides methods for screening libraries of complexes for compounds having a desired property, especially, the capacity to agonize, bind to, or antagonize a cellular receptor. The complexes in such libraries comprise a compound under test, a tag recording at least one step in synthesis ...


7
Paul K Rand, Carole A Osterweil, Robert E Newell: Indicating device. Glaxo Group, McAulay Fields Fisher Goldstein & Nissen, April 4, 1989: US04817822 (143 worldwide citation)

A device is described for indicating the number of doses dispensed from an aerosol container (2, 102) having an outlet valve member (4, 104) movable relative to the body of the container to dispense its contents in measured doses. Relative movement between the aerosol container body and the outlet m ...


8
Robert E Newell, Robert A Fitzsimmons: Pack for administering medicaments to patients. Glaxo Group, McAulay Fields Fisher Goldstein & Nissen, October 18, 1988: US04778054 (132 worldwide citation)

A pack is provided comprising a circular carrier disc provided with a plurality of containers arranged in a circle and each containing a dose of medicament in particulate form. The containers are puncturable to permit the medicament therein to be released.


9
Ian F Skidmore, Lawrence H C Lunts, Harry Finch, Alan Naylor: Phenethanolamine derivatives. Glaxo Group, Morgan & Finnegan, February 12, 1991: US04992474 (130 worldwide citation)

Phenethanolamine derivatives are disclosed of formula ##STR1## wherein m is 2 to 8; n is 1 to 7 provided that m+n is 4 to 12;


10
Davies Michael Birsha, Hearne David John, Rand Paul Kenneth, Walker Richard Ian: Inhalation device. Glaxo Group, September 25, 1991: GB2242134-A (129 worldwide citation)

An inhalation device uses a medicament pack (401) wherein at least one container (402) for powdered medicament is defined between two sheets (403, 404) peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet ...